Related Experiment Video
Updated: Oct 1, 2025
07:21
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
38.1K
Angiotensin-(1-7), a protective peptide against vascular aging
Valencia1, L Shamoon1, A Romero2
1Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Spain; Instituto de Investigación Sanitaria La Paz, IdIPAZ, Madrid, Spain.
Peptides
|March 1, 2022
Summary
Angiotensin-(1-7) combats vascular aging by protecting cells, reducing inflammation, and improving blood vessel function. This peptide shows promise in preventing age-related vascular diseases and frailty.
Area of Science:
- Cardiovascular Science
- Aging Research
- Pharmacology
Background:
- Vascular aging drives cardiovascular diseases like hypertension and atherosclerosis, accelerating frailty.
- Preventing vascular aging is crucial for public health, especially in aging populations.
- The renin-angiotensin system's protective arm, including Angiotensin-(1-7), is gaining attention for its anti-aging potential.
Purpose of the Study:
- To review the anti-aging effects of Angiotensin-(1-7) on the vasculature.
- To highlight Angiotensin-(1-7)'s role in mitigating key hallmarks of vascular aging.
Main Methods:
- Review of existing scientific literature on Angiotensin-(1-7) and vascular aging.
- Analysis of studies detailing the molecular and cellular actions of Angiotensin-(1-7).
Main Results:
- Angiotensin-(1-7) protects against vascular cell senescence and exhibits antioxidant and anti-inflammatory properties.
- It induces cytoprotective systems, ameliorates endothelial dysfunction, and reduces vascular fibrosis and calcification.
- Promotes angiogenesis and repair, counteracting age-related vascular decline.
Conclusions:
- Angiotensin-(1-7) demonstrates significant anti-aging effects on the vasculature.
- This heptapeptide is a promising therapeutic agent for preventing vascular aging and associated frailty.
- Further research is warranted to fully elucidate its anti-aging mechanisms and clinical applications.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
970
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
970
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
1.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
547
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
547
01:25Antihypertensive Drugs: Direct Renin Inhibitors
874
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
874
01:24Regulation of Angiogenesis and Blood Supply
2.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
01:29Hypertension II: Pathophysiology
130
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
130